Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 69680-146

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 69680-146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vitruvias Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Pramipexole 01)

Formula (Pramipexole 01)
Chemical structure of Pramipexole Dihydrochloride, illustrating the molecular arrangement including a thiazole ring, cyclohexane ring, and an amine group with dihydrochloride and water components.*
FDA Label Image

Tablet-pictures (Pramipexole 02)

Tablet-pictures (Pramipexole 02)
Pramipexole Dihydrochloride extended release oral tablets in two strengths: 0.375 mg and 0.75 mg. The 0.375 mg tablet is round, white, and imprinted with "002" on the front, plain on the back. The 0.75 mg tablet is round, white, and imprinted with "008" on the front, plain on the back. Manufactured by Vitruvias Therapeutics, Inc.*
FDA Label Image

Bottle-label-0.375mg (Pramipexole 03)

Bottle-label-0.375mg (Pramipexole 03)
Label for Pramipexole Dihydrochloride Extended-Release Tablets, 0.375 mg strength, packaged as 30 tablets. The label includes dosage form and strength details, instructions to swallow tablets whole, storage conditions, manufacturer Xiamen LP Pharmaceutical Co., Ltd. in China, and distributor Vitruvias Therapeutics, USA. Marked Rx Only, once daily use.*
FDA Label Image

Bottle-label-0.75mg (Pramipexole 04)

Bottle-label-0.75mg (Pramipexole 04)
Label for Pramipexole Dihydrochloride Extended-Release Tablets, 0.75 mg strength, containing 30 tablets. The label includes dosing instructions to swallow tablets whole and storage conditions. Manufactured by Xiamen LP Pharmaceutical Co., Ltd. in China and distributed by Vitruvias Therapeutics, Inc., Auburn, AL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.